| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9373444 | Journal of Pediatric Surgery | 2005 | 6 Pages |
Abstract
An injectable, fibroblast-based, engineered construct prevents midterm to long-term recanalization in a leporine model of vascular sclerotherapy. This novel therapeutic approach may prevent recurrence of vascular malformations after sclerotherapy, thus reducing the need for repeated procedures and morbid operative resections.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
C. Jason Smithers, Adam M. Vogel, Harry P.W. Kozakewich, Deborah A. Freedman, Patricia E. Burrows, Dario O. Fauza, Steven J. Fishman,